Systemic Stem Cell Therapy Reduces Malignant Mesothelioma Growth

March 20, 2014

(News-Medical.net) – Systemic delivery of stem cells expressing an apoptosis-inducing protein can successfully incorporate into malignant pleural mesothelioma (MPM) cells and subsequently induce their death, according to preclinical study findings. While further validation is needed, the research opens up the possibility of using stem cell therapy to decrease tumour burden in this rare and largely untreatable type of lung cancer.